Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2012
03/21/2012CN102379885A Pseudo-ginseng triol saponin enteric pellet and capsule and preparation method thereof
03/21/2012CN102379884A Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof
03/21/2012CN102379877A Western medicinal compound for preventing or treating myocardial ischemic chronic heart failure and application thereof
03/21/2012CN102379876A N-(3- pyridine formex oxygen radical)-3, 5- dimethyl-1- amantadine or pharmaceutically-acceptable salt for treating vascular dementia
03/21/2012CN102379875A Compound preparation containing benidipine hydrochloride and metoprolol tartrate and application thereof
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN102379871A Use of 5-(4-dimethylaminobenzylidene)-3-(2-ethoxyl)-2-phenylimino-1,3-thiazol-4-one in pharmacy
03/21/2012CN102379869A Oral preparation containing saxagliptin and application thereof
03/21/2012CN102379867A Use of chicoric acid in treatment of fundus lesion
03/21/2012CN102379864A Compound salvianic acid injection for treating cerebral vascular thrombosis diseases and preparation process thereof
03/21/2012CN102379854A Manidipine hydrochloride oral quick release preparation and preparation method thereof
03/21/2012CN102379843A Levocarnitine pharmaceutical composition for injection
03/21/2012CN102379830A Chinese herbal medicine toothpaste
03/21/2012CN102178815B Traditional Chinese medicine for treating ischemic optic neuropathy
03/21/2012CN102085178B Production process for improving stability of enoxaparin sodium injection
03/21/2012CN102028658B Solid preparation containing rosuvastain calcium liposome
03/21/2012CN101972320B Method for extracting ferulic acid, chlorogenic acid and other aicd components from coptis chinensis franch
03/21/2012CN101953865B Chinese medicinal composition for treating ischemic heart diseases and preparation method thereof
03/21/2012CN101919944B Traditional Chinese medicine compound, preparation method and application thereof
03/21/2012CN101919859B Medicinal composition containing pentoxifyllinum and etodolic acid and application thereof
03/21/2012CN101904891B Ginkgo leaf pills and preparation method thereof
03/21/2012CN101884674B Chinese medicament for preventing and treating hypertension
03/21/2012CN101862337B Drug composite containing limaprost and preparation method thereof
03/21/2012CN101810576B Puerarin self-microemulsion composition based on mixed oil and preparation method thereof
03/21/2012CN101732399B Three-herb tea for lowering pressure
03/21/2012CN101721706B Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
03/21/2012CN101716271B Chinese traditional medicine effective fraction composite used for curing coronary heart disease and preparation method thereof
03/21/2012CN101708202B Medicament for inhibiting asodilatatioin
03/21/2012CN101628905B C-aryl glucoside sglt2 inhibitors and method
03/21/2012CN101623332B Method for preparing rhizoma corydalis decumbeutis total alkaloids acid salt freeze-drying substance and application of obtained freeze-drying substance
03/21/2012CN101622003B Therapeutic agent for ameliorating prognosis after lower limb amputation surgery
03/21/2012CN101591386B Polypeptide capable of inhibiting excitable and toxic damages and use thereof
03/21/2012CN101591310B Method for preparing cinepazide maleate
03/21/2012CN101559227B Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions
03/21/2012CN101549050B Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof
03/21/2012CN101379048B Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
03/21/2012CN101229241B Application of Chinese traditional medicine compounds on preparing medicines promoting mesenchymal stem cells surviving in the body and cardioblast differentiation
03/21/2012CN101199564B Application of sanchi flower total saponine in preparing treatment hypertension disease medicament
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012US8138200 Compositions and methods for double-targeting virus infections and targeting cancer cells
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8137969 Neural progenitor cells derived from embryonic stem cells
03/20/2012US8137904 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/20/2012US8137662 Proliferated cell lines and uses thereof
03/20/2012CA2672656C Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2540196C Pyridine derivatives and use thereof as urotensin ii antagonists
03/20/2012CA2515293C Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
03/20/2012CA2514507C Methods and compositions for the treatment of gastrointestinal disorders
03/20/2012CA2453510C Treatment of fatigue and cognitive side effects associated with cancer, cancer treatments and menopause with d-threo-methyphenidate
03/20/2012CA2446872C Immune-modulating peptide
03/20/2012CA2405469C Integrin binding peptide derivatives
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/20/2012CA2392453C Modulation of signal transduction
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells
03/15/2012WO2012033789A2 Treatment of diseases
03/15/2012WO2012033353A2 Sesterterpene compounds and use thereof
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033149A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012WO2012032545A1 Processes for preparing dronedarone and its intermediates
03/15/2012WO2012032334A1 Quinoline and quinoxaline derivatives as kinase inhibitors
03/15/2012WO2012031534A1 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine, preparation method and pharmaceutical use thereof
03/15/2012WO2012031445A1 Processes for preparing piperazinium salts of kmup and use thereof
03/15/2012WO2012031383A1 Amide compounds
03/15/2012WO2012006516A3 Protein kinase c activators and anticoagulant for the treatment of stroke
03/15/2012WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/15/2012WO2011160845A3 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment
03/15/2012WO2011146589A8 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
03/15/2012WO2011103552A3 Amp derivatives for treating cardiac diseases
03/15/2012WO2011018763A8 Combination of proanthocyanidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis
03/15/2012US20120066775 Stresscopins and their Uses
03/15/2012US20120065573 Methods of Treating Vascular Lesions
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120065264 SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID
03/15/2012US20120065253 Genetic modification of targeted regions of the cardiac conduction system
03/15/2012US20120065237 Methods for treating transthyretin amyloid diseases
03/15/2012US20120065236 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065231 Thiophene derivative
03/15/2012US20120065227 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
03/15/2012US20120065219 Spirocyclic azaadamantane derivatives and methods of use
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065213 C-met protein kinase inhibitors
03/15/2012US20120065212 Heteroarylmethyl amides
03/15/2012US20120065207 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065202 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/15/2012US20120065199 Substituted quinolines for use as vegf inhibitors
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065190 Benzazepine compounds as cgrp receptor antagonists
03/15/2012US20120065189 Heterocyclic compounds for the treatment of stress-related conditions
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065181 Method of providing neuroprotection using substituted porphyrins
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065171 Fostriecin derivatives and the pharmaceutical uses thereof
03/15/2012US20120065168 Pharmaceutical Hypocholesterolemic Compositions